Associated Papers
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant.
Lim SY et al.
Npj Parkinson's Disease, 2025
39988587 (PubMed )
Supplement: 41531_2025_884_MOESM2_ESM.xlsx › Controls
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Ross OA et al.
The Lancet. Neurology, 2011
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.
Nuytemans K et al.
Human Mutation, 2010
20506312 (PubMed )
Supplement: humu0031-0763-SD1.pdf
Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
Gao L et al.
European Journal of Neurology, 2009
Select a paper to view details